DAS-181

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name

DAS-181

DrugBank Accession Number

DB15313

Background

DAS-181 is under investigation in clinical trial NCT00527865 (Single Dose Escalating Study of DAS181 in Adults).

Type

Biotech

Groups

Investigational

Synonyms

External IDs

Indication: Not Available
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings: Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics: Not Available
Mechanism of action: Not Available
Absorption: Not Available
Volume of distribution: Not Available
Protein binding: Not Available
Metabolism: Not Available
Route of elimination: Not Available
Half-life: Not Available
Clearance: Not Available
Adverse Effects: Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity: Not Available
Pathways: Not Available
Pharmacogenomic Effects/ADRs: Not Available

Drug Interactions: This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions: Not Available

Clinical Trials

Phase	Status	Purpose	Conditions	Count
3	Recruiting	Treatment	Coronavirus Disease 2019 (COVID‑19) / Immunocompromised / Lower Respiratory Tract Infection (LRTI) / Parainfluenza	1
2	Completed	Treatment	Flu caused by Influenza	2
2	Completed	Treatment	Parainfluenza	2
2	Not Yet Recruiting	Treatment	Coronavirus Disease 2019 (COVID‑19) / Influenza Infection / SAD-RV Infection and COVID-19	1
2	Withdrawn	Treatment	Parainfluenza Infections	1
2, 3	Withdrawn	Treatment	Coronavirus Disease 2019 (COVID‑19)	1
1	Completed	Treatment	Asthma / Bronchiectasis	1
1	Completed	Treatment	Flu caused by Influenza	3
1	Completed	Treatment	Healthy Subjects (HS)	1
Not Available	Completed	Treatment	Coronavirus Disease 2019 (COVID‑19)	1

Drug created at May 20, 2019 15:12 / Updated at July 03, 2020 17:52